Robert Bindert Huizinga - EVP of Research at Aurinia Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP of Research
Stock Symbol
AUPH on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Bindert Huizinga since 11/21/2023

Holdings reported by Robert Bindert Huizinga for Aurinia Pharmaceuticals Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 69.4K $781K $11.26 Mar 2, 2022 Direct
Stock Option (right to buy) 107K Mar 2, 2022 Direct Common Stock
Restricted Stock Unit 62.4K Mar 2, 2022 Direct Common Shares

Transactions reported by Robert Bindert Huizinga for Aurinia Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.